Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma).
Ozgocmen
Salih
S
Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Firat University, Elazig, Turkey. sozgocmen@hotmail.com
Kaya
Arzu
A
Coskun
Basak Kandi
BK
D000284:Administration, Oral; D000287:Administration, Topical; D000779:Anesthetics, Local / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005672:Fusidic Acid / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012883:Skin Ulcer / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000779:Anesthetics, Local; D000890:Anti-Infective Agents; D005672:Fusidic Acid; D002939:Ciprofloxacin; D008012:Lidocaine